Why India’s health workers don’t want a homegrown vaccine
Epidemiologist and public health experts say the Covaxin approval was rushed, but efficacy data from a trial on 26,000 volunteers will be out soon
25 February 2021 - 14:06
New Delhi — India is struggling to convince its health and front-line workers to take a homegrown Covid-19 vaccine controversially approved without late-stage efficacy data, government data showed on Thursday, days ahead of a wider rollout.
The country has the world’s second-highest number of Covid-19 infections after the US, with cases recently surging as mask-wearing declines and states have eased social-distancing measures. A lack of confidence in a homegrown vaccine country could prevent India from meeting its target of vaccinating 300-million of its 1.35-billion people by August...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.